Parallel Group Design¶

Two-arm parallel group Phase II efficacy study simulation.

Design¶

Type: Parallel, 1:1 randomization
Arms: Placebo vs Active (100 mg QD)
Duration: 28 days
N per arm: 50 subjects
Endpoints: PK exposure

Features Demonstrated¶

Parallel design creation
Treatment arm specification
QD dosing regimen
Dropout modeling
Compliance patterns
Trial simulation

Files¶

File	Description
python.py	Python implementation
julia.jl	Julia implementation
cli.json	CLI specification

Expected Output¶

Phase 2 Parallel Study
======================
Design: 2-arm parallel (1:1)
Duration: 28 days

Arm Results:
  Placebo: 48/50 completed (96.0%)
  Active:  47/50 completed (94.0%)

Overall completion: 95.0%
Overall compliance: 89.5%